Industry News
Clinuvel files for marketing approval for SCENESSE in Europe
Melbourne-based Clinuvel (ASX:CUV) has applied for the right to market its SCENESSE subdermal treatment in the EU as a treatment for erythropoietic protoporphyria. [ + ]
Book Review: The Genome Generation
Dr Elizabeth Finkel showcases the dramatic changes that have occurred in our understanding of genetics only a decade after the human genome was first sequenced. [ + ]
Alchemia making US inroads with coagulant
Alchemia Limited has revealed it is now selling more than $1.4 million per week worth of its lead drug, fondaparinux, in the US. [ + ]
AusBiotech linked in to the industry network
AusBiotech's two groups on social networking site LinkedIn have grown rapidly in the past year, this week reaching more than 1500 members (combined), cementing their place as the largest networks of their kind for Australian biotechnology and medical technology. [ + ]
State-of-the-art DNA lab for WA Museum
John Day - Minister for Planning; Culture and the Arts; Science and Innovation - has officially opened a new science and research facility at the Western Australian Museum’s Collection and Research Centre. [ + ]
Getting to the heart of microRNAs
A new study reveals the diversity of microRNAs present in the heart, giving some insight into cardiac function and disease. [ + ]
Prima enrols first patient for cancer trial
Sydney's Prima BioMed (ASX:PRR) has enrolled the first participant for an 800-member trial of its CVac ovarian cancer treatment in post-chemotherapy patients. [ + ]
Adam Equipment celebrates 40th anniversary in 2012
Adam Equipment is celebrating its 40th anniversary in 2012. Since its inception, Adam has supplied professionals across a range of industries with balances and scales for various uses, including weighing, counting, price calculating and inventory control. [ + ]
National research cloud will allow for rapid sharing and collaboration on data
The National eResearch Collaboration Tools and Resources (NeCTAR) project is partnering with Australian research institutions to create a national research cloud purpose-built for Australian researchers. [ + ]
Biotechs recover from slump in Q2
Australia's life science industry performed relatively well in the December 2011 quarter despite macroeconomic pressures, according to the PricewaterhouseCoopers BioForum Report, with indicators good for the near future. [ + ]
Malaria bigger killer than previously thought
A new study found more than 1.2 million people died from malaria in 2010, although the disease is on the decline thanks to new treatments. [ + ]
Roche Diagnostics announces Dan Zabrowski as new Head of Roche Applied Science
As of 1 February 2012, Dan Zabrowski is Head of Roche Applied Science in the Diagnostics Division, located in Penzberg, Germany. He succeeds Paul Brown. [ + ]
Sigma-Aldrich completes acquisition of BioReliance
Sigma-Aldrich has completed its acquisition of BioReliance Holdings from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments. [ + ]
Grace receives patent notice of allowance for flash chromatography technology
WR Grace & Co has received a Notice of Allowance from the US Patent and Trademark Office for a patent application related to its Reveleris flash chromatography system. [ + ]
Comment: Cloud empowers scientists to accelerate innovation
Global real-time collaboration and rapid access to vast data resources are spurring scientific innovation and discovery. [ + ]
